Evidence map›Paper›PMID 22006816›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2012

Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.

Victoria E DeMambro, Laura Maile, Christine Wai, Masanobu Kawai, Teresa Cascella, Clifford J Rosen, David Clemmons

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Vanadium Compound Treatment Modulates MC3t3-E1 Osteoblast Function.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Propranolol Promotes Bone Formation and Limits Resorption Through Novel Mechanisms During Anabolic Parathyroid Hormone Treatment in Female C57BL/6J Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  18. Article
  19. IGFBP-2 - taking the lead in growth, metabolism and cancer.Journal of cell communication and signaling · 2015
    Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Victoria E DeMambroMaine Medical Center Research Institute, Scarborough, ME, USA.
Laura Maile
Christine Wai
Masanobu Kawai
Teresa Cascella
Clifford J Rosen
David Clemmons
University of North Carolina at Chapel Hill · USMaine Medical Center Research Institute · US

Funding

WNT SIGNALING IN PREIMPLANTATION EMBRYOP20RR018789 · NCRR · MAINE MEDICAL CENTER · PI WANG, ZACK Z. · 2003 to 2011
$18.9M
Role of Integrins/ECM in Controlling IGF-I ActionsR37AG002331 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CLEMMONS, DAVID ROBERT · 2004 to 2013
$3.7M
Determination of the Mechanisms by which IGFBP-2 Stimulates Bone RemodelingR01AR061164 · NIAMS · MAINEHEALTH · PI CLEMMONS, DAVID ROBERT, ROSEN, CLIFFORD JAMES · 2011 to 2015
$2.4M
A Chromosome 10 QTL Associated with IGF-1 and Bone MassR01AR053853 · NIAMS · MAINEHEALTH · PI ROSEN, CLIFFORD JAMES · 2007 to 2010
$2.2M
THE EFFECT OF AGING ON HORMONAL CONTROL OF REPLICATIONR01AG002331 · NIA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CLEMMONS, DAVID ROBERT · 1985 to 2002
$1.0M
NCRR NIH HHS P20 RR18789NIAMS NIH HHS AR053853NIAMS NIH HHS AR061164NIAMS NIH HHS R01 AR053853NIAMS NIH HHS R01 AR061164NIA NIH HHS AG02331NIA NIH HHS R01 AG002331NIA NIH HHS R37 AG002331
6 · The paper itself

Abstract

Global deletion of the Igfbp2 gene results in the suppression of bone turnover. To investigate the role of insulin-like growth factor-binding protein-2 (IGFBP-2) in regulating osteoclast differentiation, we cultured Igfbp2(-/-) bone marrow cells and found a reduction in the number of osteoclasts and impaired resorption. Addition of full-length IGFBP-2 restored osteoclast differentiation, fusion, and resorption. To determine the molecular domains of IGFBP-2 that were required for this effect to be manifest, Igfbp2(-/-) bone marrow cells were transfected with constructs in which the heparin-binding (HBD) or the IGF-binding domains of IGFBP-2 were mutated. We found that both domains were necessary for osteoclastogenesis because expression of the mutated forms of either domain failed to support the formation of functionally mature osteoclasts. To discern the mechanism by which IGFBP-2 regulates osteoclast formation, PTEN abundance and phosphorylation status as well as AKT responsiveness to IGF-I were analyzed. Igfbp2(-/-) cells had elevated levels of PTEN and phospho-PTEN compared with controls. Expression of wild-type IGFBP-2 reduced the level of PTEN to that of wild-type cells. Cells expressing the IGF-binding mutant showed suppression of PTEN and phospho-PTEN equivalent to the wild-type protein, whereas those expressing the IGFBP-2 HBD mutant showed no PTEN suppression. When the ability of IGF-I to stimulate AKT activation, measured by Thr³⁰⁸ and Ser⁴⁷³ phosphorylation, was analyzed, stimulation of Ser⁴⁷³ in response to IGF-I in preosteoclasts required the presence of intact IGFBP-2. This effect was duplicated by the addition of a CK2 inhibitor that prevents the phosphorylation of PTEN. In contrast, in fully differentiated osteoclasts, stimulation of Thr³⁰⁸ phosphorylation required the presence of intact IGFBP-2. We conclude that IGFBP-2 is an important regulator of osteoclastogenesis and that both the heparin- and the IGF-binding domains of IGFBP-2 are essential for the formation of fully differentiated and functional osteoclasts.

Indexed as

Cell DifferentiationAcid PhosphataseAnimalsBone MarrowBone ResorptionCell ProliferationFemaleHumansInsulin-Like Growth Factor Binding Protein 2Insulin-Like Growth Factor IIsoenzymesMacrophage Colony-Stimulating FactorMaleMiceMutant ProteinsOsteoclastsAcid PhosphataseInsulin-Like Growth Factor Binding Protein 2Insulin-Like Growth Factor IIsoenzymesMacrophage Colony-Stimulating FactorMutant ProteinsProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRecombinant ProteinsTartrate-Resistant Acid Phosphatase

Identifiers

PMID22006816
PMCPMC3385417
OpenAlexW2114752593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.